(Q37128099)

18 August 2017

1 reference

title

Prazosin for treatment of nightmares related to posttraumatic stress disorder (English)

1 reference

post-traumatic stress disorder

18 August 2017

0 references

1 reference

Heather R Taylor

1

1 reference

PubMed ID

18387899

18 August 2017

Maisha Kelly Freeman

series ordinal

2

1 reference

PubMed ID

18387899

18 August 2017

Marshall E Cates

series ordinal

3

1 reference

18 August 2017

1 April 2008

1 reference

American Journal of Health-System Pharmacy

18 August 2017

1 reference

18 August 2017

65

1 reference

18 August 2017

8

1 reference

18 August 2017

716-722

1 reference

Research on posttraumatic stress disorder: epidemiology, pathophysiology, and assessment

18 August 2017

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

Clinical case series: the use of Prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

The development of a Clinician-Administered PTSD Scale

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

Practicable and valid approach to evaluate the efficacy of nootropic drugs by means of rating scales.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

Nightmare frequency in sexual assault survivors with PTSD.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070124

31 March 2020

Identifiers

DOI

10.2146/AJHP070124

1 reference

18 August 2017

1 reference

PubMed ID

18387899